ATE397072T1 - Adh7-nukleotide - Google Patents

Adh7-nukleotide

Info

Publication number
ATE397072T1
ATE397072T1 AT99933376T AT99933376T ATE397072T1 AT E397072 T1 ATE397072 T1 AT E397072T1 AT 99933376 T AT99933376 T AT 99933376T AT 99933376 T AT99933376 T AT 99933376T AT E397072 T1 ATE397072 T1 AT E397072T1
Authority
AT
Austria
Prior art keywords
adh7
nucleotides
mutations
parkinson
relates
Prior art date
Application number
AT99933376T
Other languages
English (en)
Inventor
Lars Olson
Silvia Buervenich
Olof Sydow
Maria Anvret
Zhiping Zhang
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802294A external-priority patent/SE9802294D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE397072T1 publication Critical patent/ATE397072T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT99933376T 1998-06-26 1999-06-23 Adh7-nukleotide ATE397072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9092598P 1998-06-26 1998-06-26
SE9802294A SE9802294D0 (sv) 1998-06-26 1998-06-26 ADH7 nucleotides

Publications (1)

Publication Number Publication Date
ATE397072T1 true ATE397072T1 (de) 2008-06-15

Family

ID=26663341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933376T ATE397072T1 (de) 1998-06-26 1999-06-23 Adh7-nukleotide

Country Status (6)

Country Link
EP (1) EP1090127B1 (de)
AT (1) ATE397072T1 (de)
AU (1) AU4944099A (de)
DE (1) DE69938833D1 (de)
ES (1) ES2306517T3 (de)
WO (1) WO2000000621A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
US6511834B1 (en) * 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
WO2002024958A1 (en) * 2000-09-19 2002-03-28 Genaissance Pharmaceuticals, Inc. Haplotypes of the adh7 gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Also Published As

Publication number Publication date
WO2000000621A8 (en) 2000-03-16
DE69938833D1 (de) 2008-07-10
EP1090127B1 (de) 2008-05-28
AU4944099A (en) 2000-01-17
ES2306517T3 (es) 2008-11-01
EP1090127A1 (de) 2001-04-11
WO2000000621A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
AU3368497A (en) Human dnase i hyperactive variants
WO1998009657A3 (en) Method for recombinant adeno-associated virus-directed gene therapy
KR970701776A (ko) 형질전환 성장 인자 알파 에이치1(Transforming growth factor alpha H1)
CA2414772A1 (en) Prevention and treatment of alzheimer's disease
EP1440980A3 (de) Peptidanaloge des menschlichen, basischen Myelinproteins
WO2001016330A3 (en) Prevention of affections associated with porcine circovirus-2
HU229045B1 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
AU3780901A (en) Pharmaceutical composition for muscular anabolism
EP0797999A3 (de) Fettleibigkeitprotein-Formulierungen
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
KR970701724A (ko) 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin)
WO1998011234A3 (en) Human protein kinases
WO2003084979A3 (fr) Peptides et leur application en therapeutique
WO2002081507A3 (en) Interferon gamma polypeptide variants
ATE397072T1 (de) Adh7-nukleotide
DE69636052D1 (de) Mpl-liganden analoga
AU3390995A (en) Novel implant and novel vector for the treatment of acquired diseases
IT1294967B1 (it) Composizione immunogenica da tlp
EP0969859A1 (de) Verwendung von aus tierorganen extrahierbaren proteinen zur herstellung von arzneimitteln zur behandlung von pathologischen, von hyperproduktion des tnf charakterisierten zuständen
CA2211413A1 (en) Human dnase i variants
DK0811068T3 (da) Humane DNase I varianter
SE9503379D0 (sv) A modified GAD, a method for producing a modified GAD, a method for supplying a modified GAD, a peptide and the use of an ordinary and/or a modified GAD
WO2001034181A3 (en) Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene
WO2004089980A3 (en) Therapeutic cancer vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties